Aller au contenu principal
Profil bibliographique

Silje Zandstra Krokeide

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

19Publications signalées
565Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Immune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies ResearchDNA Repair Mechanisms

Les publications récentes

2026 conference-abstract OpenAlex

Abstract 1598: Preclinical efficacy of a bispecific NK cell engager studied using a humanized multiple myeloma mouse model

Mari I. Suominen, Katja M. Fagerlund, Mervi Ristola, Justyna Zdrojewska et autres

Abstract Natural killer (NK) cells are an essential part of the innate immune system as they can recognize and eliminate various cells in distress, such as virus-infected and tumor cells. Several promising therapeutics based on NK cell function are currently being developed …

fi, se, no (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2025 conference-abstract OpenAlex

Ex vivo expanded adaptive NK cells in combination with a bispecific NK cell engager targeting BCMA for synergistic control of multiple myeloma

Thorstein Boxaspen, Hannah Cuthbertson Husbyn, Kim Anh Giang, C. Heinz et autres

Abstract T cell-based therapies have transformed the treatment landscape for multiple myeloma (MM). However, most patients receiving autologous CAR-T therapy ultimately relapse, and allogeneic T cell products face significant clinical hurdles, including the risk of graft-versus-host disease. Additionally, T cell engagers are …

no, se, fi (code pays fourni par la source)

2 citations Blood
Accès ouvert 2025 preprint OpenAlex

Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cells

Minoru Kanaya, Camille Philippon, Herman Netskar, Michelle Sætersmoen et autres

Induced pluripotent stem cell (iPSC)-derived natural killer (iNK) cells offer a promising platform for off-the-shelf immunotherapy against hematological malignancies. NK cell function is dynamically regulated through education driven by inhibitory receptors, including CD94/NKG2A and killer cell immunoglobulin-like receptors (KIR). However, the acquisition …

no, se, us (code pays fourni par la source)

2 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor

Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga, Jorge Mansilla‐Soto et autres

Background Human leukocyte antigen (HLA)-E is overexpressed by a large proportion of solid tumors, including malignant glioblastoma, and acts as a major checkpoint for NKG2A + CD8 + T cells and natural killer (NK) cells in the tumor microenvironment and circulation. This …

no, us, se (code pays fourni par la source)

25 citations Med
Accès ouvert 2024 article OpenAlex

The G Protein–Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration

Daniel Palacios, Rakesh Kumar Majhi, Edina K. Szabo, Dennis Clement et autres

G protein-coupled receptors (GPCRs) represent the largest family of surface receptors and are responsible for key physiological functions, including cell growth, neurotransmission, hormone release, and cell migration. The GPCR 56 (GPR56), encoded by ADGRG1, is an adhesion GPCR found on diverse cell …

no, in, pl, fi, se (code pays fourni par la source)

8 citations The Journal of Immunology
Accès ouvert 2024 article OpenAlex

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies

Quirin Hammer, Karlo Perica, Rina M. Mbofung, Hanna van Ooijen et autres

Allogeneic cellular immunotherapies hold promise for broad clinical implementation but face limitations due to potential rejection of donor cells by the host immune system. Silencing of beta-2 microglobulin (B2M) expression is commonly employed to evade T cell-mediated rejection by the host, although …

se, us, no (code pays fourni par la source)

40 citations Cell stem cell
Accès ouvert 2023 preprint OpenAlex

Targeting HLA-E Positive Cancers with a Novel NKG2A/C Switch Receptor

Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga, Jorge Mansilla‐Soto et autres

Abstract HLA-E is overexpressed by approximately 80% of solid tumors, including malignant glioblastoma, and is emerging as a major checkpoint for NKG2A + CD8 + T cells and NK cells in the tumor microenvironment and circulation. This axis operates side-by-side with PD-L1 …

no, us, se (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2023 preprint OpenAlex

Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells

Quirin Hammer, Karlo Perica, Hanna van Ooijen, Rina M. Mbofung et autres

SUMMARY Allogeneic cell therapies hold promise for broad clinical implementation, but face limitations due to potential rejection by the recipient immune system. Silencing of beta-2-microglobulin ( B2M ) expression is commonly employed to evade T cell-mediated rejection, although absence of B2M triggers …

se, us, no (code pays fourni par la source)

7 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2023 article OpenAlex

The Lysosomal Calcium Channel TRPML1 Maintains Mitochondrial Fitness in NK Cells through Interorganelle Cross-Talk

Dennis Clement, Edina K. Szabo, Silje Zandstra Krokeide, Merete Thune Wiiger et autres

Cytotoxic lymphocytes eliminate cancer cells through the release of lytic granules, a specialized form of secretory lysosomes. This compartment is part of the pleomorphic endolysosomal system and is distinguished by its highly dynamic Ca2+ signaling machinery. Several transient receptor potential (TRP) calcium …

no, us, kr, de, gb, in, se (code pays fourni par la source)

22 citations The Journal of Immunology
Accès ouvert 2023 article OpenAlex

Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells

Kim Anh Giang, Thorstein Boxaspen, Yumei Diao, Johan Nilvebrant et autres

We describe the development and characterization of the (to date) smallest Natural Killer (NK) cell re-directing human B Cell Maturation Antigen (hBCMA) x CD16 dual engagers for potential treatment of multiple myeloma, based on combinations of small 58 amino acid, non-immunoglobulin, affibody …

se, no (code pays fourni par la source)

14 citations New Biotechnology
2022 article OpenAlex

Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection

Quirin Hammer, Karlo Perica, Rina M. Mbofung, Hanna van Ooijen et autres

Allogeneic cell therapies hold promise to be cost effective with scaled manufacturing for multi-dosing and on-demand off-the-shelf availability. A critical consideration for allogeneic cell products is their ability to persist, maintain function and avoid rejection by the patient's immune system. Genetic knockout …

se, us, no (code pays fourni par la source)

6 citations Blood
2022 article OpenAlex

Affibody-Based BCMA x CD16 Dual Engagers for Activation of NK Cells Towards Multiple Myeloma

Kim Anh Giang, Mizuha Kanaya, Thorstein Boxaspen, Minoru Kanaya et autres

The re-direction of natural killer (NK) cells is an emerging strategy for cancer immunotherapy. We describe the development and characterization of the so far smallest NK cell re-directing hBCMA x CD16 dual engagers for potential multiple myeloma treatment based on combinations of …

se, no (code pays fourni par la source)

3 citations Blood

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.